Sign in
Taking people in United StatesNo phase

Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment

Key facts

Who runs it
University of Notre Dame
Where
Notre Dame, United StatesSee the site
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
24 Mar 2026
Expected to end
1 Mar 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Brief opioid-informed alcohol treatment
Record updated
9 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Participants must be taking prescribed buprenorphine for at least 2 weeks
  • Participants must be 18 years or older
  • Meet DSM-5 criteria for alcohol use disorder (AUD)
  • Participants must report alcohol use ≥ 1 day/week on average in the past 28 days
  • Participants must be able to read simple English

Who cannot take part

  • Currently receiving formal alcohol use treatment
  • Currently experiencing psychosis

Where in United States

  • The University of Notre DameNotre Dame, United StatesContact: Beth A Arnold, M.S.Taking people

About the trial

What the trial wants to find out

This study will help determine the feasibility and acceptability of a brief opioid-informed alcohol intervention in patients receiving prescribed buprenorphine for opioid use who are currently drinking alcohol. It will also provide initial information on whether the intervention improves outcomes related to alcohol use. The results of this proof-of-concept study will inform whether a future larger clinical trial is warranted.

The 2 groups in the trial

  • Treatment As UsualNo study treatment, for comparison

    No intervention is administered. All participants in this study receive prescribed buprenorphine for opioid use disorder and may, related to this, receive behavioral intervention focused on medication adherence and preventing opioid relapse. Treatment As Usual refers to receiving this and no additional intervention.

  • Experimental: Brief opioid-informed alcohol treatmentTreatment being tested

    The brief opioid-informed alcohol treatment is based upon principles of Motivation Enhancement Therapy (MET) and Cognitive Behavioral Therapy (CBT) tailored to the needs of patients in opioid treatment. Delivered once per week for 4 weeks.

    Treatment: Brief opioid-informed alcohol treatment

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Better Experiences in Substance Treatment: A Brief Alcohol-Focused Intervention Tailored for Patients in Opioid Agonist Treatment
Record updated
9 June 2026